Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Melanoma, Skin cancer
Closed
Phase 3
This study is looking at a new drug called PDR001. It is for people whose melanoma:
cannot be removed with surgery or has spread elsewhere in the body
cells have a change in a gene called BRAF
Recruitment start: 7 March 2017
Recruitment end: 6 June 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr. James Larkin
Novartis
Last reviewed: 10 June 2018
CRUK internal database number: 14512